CAZZANIGA MARINA ELENA

Ruolo: 
Ricercatore a tempo determinato
Settore scientifico disciplinare: 
ONCOLOGIA MEDICA (MED/06)

Pubblicazioni

  • Krasniqi, E., Pizzuti, L., Barchiesi, G., Sergi, D., Carpano, S., Botti, C., et al. (2020). Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence. JOURNAL OF CELLULAR PHYSIOLOGY. Dettaglio
  • Jacobs, S., Robidoux, A., Abraham, J., Pérez-Garcia, J., La Verde, N., Orcutt, J., et al. (2020). Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer. BREAST CANCER RESEARCH, 22(1). Dettaglio
  • Pizzuti, L., Krasniqi, E., Barchiesi, G., Della Giulia, M., Izzo, F., Sanguineti, G., et al. (2020). Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting. INTERNATIONAL JOURNAL OF CANCER, 146(7), 1917-1929. Dettaglio
  • Ellinghaus, D., Degenhardt, F., Bujanda, L., Buti, M., Albillos, A., Invernizzi, P., et al. (2020). Genomewide Association Study of Severe Covid-19 with Respiratory Failure. NEW ENGLAND JOURNAL OF MEDICINE. Dettaglio
  • Cavaletti, G., Cornblath, D., Merkies, I., Postma, T., Rossi, E., Alberti, P., et al. (2019). Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 24(1), 111-119. Dettaglio